Pharmaceutical grade, suitable for reconstitution of research peptides
Providers should transition to emerging weight loss peptides when a patient experiences intractable side effects (like severe nausea or gastroparesis), when they hit a hard weight loss plateau despite dietary compliance, or when the primary clinical obstacle is documented cellular metabolic resistance rather than hyperphagia (overeating)
In this context, only the inactive form of vitamin B12 in the human body, cyanocobalamin, is converted to active forms by a single agent, glutathione, to a limited extent
Epithalon is a compounded peptide used in clinical practice under off-label provisions, consistent with how most peptide therapies are prescribed in the United States
Separate vials let the TB-4 or TB-500 dose rise without multiplying the other two peptides